Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 684.27 | 1855.00 | 1721.75 | 1.0774 | 1.1152 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1312.00 | 1721.75 | 0.7620 | 0.6307 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 684.27 | 1936.00 | 1721.75 | 1.1244 | 1.1842 |
| BT-20 | Lapatinib | 10 | uM | 9 | 1250.00 | 684.27 | 697.00 | 1721.75 | 0.4048 | 0.0139 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1815.00 | 1721.75 | 1.0542 | 1.0808 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1954.00 | 1721.75 | 1.1349 | 1.1994 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 684.27 | 1781.00 | 1721.75 | 1.0344 | 1.0515 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1596.00 | 1721.75 | 0.9270 | 0.8892 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1575.00 | 1721.75 | 0.9148 | 0.8705 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1801.00 | 1721.75 | 1.0460 | 1.0688 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1557.00 | 1721.75 | 0.9043 | 0.8545 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 684.27 | 554.00 | 1721.75 | 0.3218 | -0.1467 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 957.00 | 1721.75 | 0.5558 | 0.2866 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2081.00 | 1721.75 | 1.2087 | 1.3060 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2072.00 | 1721.75 | 1.2034 | 1.2985 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2134.00 | 1721.75 | 1.2394 | 1.3499 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 684.27 | 677.00 | 1721.75 | 0.3932 | -0.0080 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2184.00 | 1721.75 | 1.2685 | 1.3912 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2162.00 | 1721.75 | 1.2557 | 1.3731 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2157.00 | 1721.75 | 1.2528 | 1.3690 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 684.27 | 1889.00 | 1721.75 | 1.0971 | 1.1442 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 684.27 | 1008.00 | 1721.75 | 0.5855 | 0.3377 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1940.00 | 1721.75 | 1.1268 | 1.1876 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 2029.00 | 1721.75 | 1.1785 | 1.2626 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 684.27 | 593.00 | 1721.75 | 0.3444 | -0.1020 |